Page last updated: 2024-08-24

valsartan and Arteriosclerosis Obliterans

valsartan has been researched along with Arteriosclerosis Obliterans in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Q; Feng, N; Wang, F; Wang, L; Yao, W1

Trials

1 trial(s) available for valsartan and Arteriosclerosis Obliterans

ArticleYear
Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial.
    Medical science monitor : international medical journal of experimental and clinical research, 2020, Jun-16, Volume: 26

    Topics: Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis Obliterans; C-Reactive Protein; Endovascular Procedures; Enzyme-Linked Immunosorbent Assay; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Interleukin-6; Male; Middle Aged; Peripheral Arterial Disease; Single-Blind Method; Stents; Valsartan

2020